Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1987 of 6351
-
Can a Once-Daily cream tame psoriasis in toddlers?
Disease control CompletedThis is a Phase 2, open label, maximal usage PK and safety study of ARQ-151 cream 0.3% in pediatric subjects (ages 2 to 5 years old) with plaque psoriasis:
Phase 2 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Own stem cells may heal scarred vocal cords and restore voice
Disease control CompletedThe overall aim of the project is to develop a new method for treatment of untreatable severe hoarseness due to vocal fold scarring by local injection of autologous mesenchymal stromal cells (MSC). At present there is no lasting effective treatment for this condition which result…
Phase 1/2 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Acupuncture needles take on Chemo's nerve damage
Symptom relief CompletedThis three-armed, multicenter, randomized, parallel, sham-controlled clinical trial will conduct in three centers in Taiwan. The investigators will randomly assign 234 eligible patients into three groups, an acupuncture group (n=90), a sham-controlled group (n=90), and a waitlist…
Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Could 'Zombie Cells' be behind long COVID? new study aims to find out
Knowledge-focused OngoingThe purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which selectively eliminate senescent cells, should be initiated.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Coffee as medicine? major trial tests caffeine against Alzheimer's
Symptom relief Recruiting nowSporadic Alzheimer's disease is a multifactorial illness arising a major medico-economic stakes for our aging societies. There is currently no curative treatment available. Coffee is a complex beverage with psychostimulant properties whose main effective element, caffeine, has a…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Could Pre-Surgery radiation make inoperable breast tumors removable?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of neoadjuvant radiation therapy in improving local-regional control and facilitating surgical conversion in patients with inoperable locally advanced breast cancer after 2-6 courses of neoadjuvant chemotherapy. Thi…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a Low-Dose blood thinner keep clots away?
Disease control CompletedDesign: U.S.-based, single-center, randomized placebo-controlled trial. Brief Treatment Description: Low-intensity apixaban (2.5mg twice daily) for extended-duration secondary prevention of VTE after initial treatment for provoked VTE. Purpose: To establish the safety and effic…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Family planning visits could double as HIV prevention for young women
Prevention CompletedThis a prospective, open-label implementation project to catalyze integration of HIV prevention and PrEP care services for adolescent girls and young women in family planning clinics in Kenya.
Phase 4 • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 26, 2026 13:32 UTC
-
Tailored talk therapy shows promise for Non-Verbal kids with autism
Symptom relief OngoingThis research study, Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM), is designed to maximize language outcomes for limited-language preschoolers, thereby lowering the risk of being classified as "minimally verbal" at age 6, by em…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
A sharper eye on amyloid: could quantitative scans revolutionize cardiac monitoring?
Diagnosis Recruiting nowRecently, treatment with tafamidis in patients with cardiac ATTR lead to a significant reduction in mortality. The Perugini score is commonly used on planar bone scans to differentiate cardiac ATTR from other amyloidosis or normal patients but fails to evaluate amyloid burden and…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Could a simple nerve zap help veterans heal from brain injury and PTSD?
Symptom relief Recruiting nowMild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are important conditions for the Veterans Administration (VA) that frequently occur together in combat Veterans from the conflicts in Afghanistan and Iraq. In many Veterans these become chronic, raising t…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can these pills help veterans with PTSD finally sleep?
Symptom relief CompletedMany Veterans with posttraumatic stress disorder (PTSD) have trouble sleeping or have frequent nightmares. So far, no medication has been approved for treatment of insomnia in PTSD. The purpose of this research study is to find out if taking medications called trazodone or eszopi…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows promise for tough head and neck cancers
Disease control CompletedThis is a single-arm, non-randomized pilot study to evaluate the efficacy and tolerability of combination quad-shot palliative radiotherapy with immunotherapy for advanced/recurrent/metastatic head and neck cancer.
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Cancer-Fighting virus injected directly into tumors shows promise in early trial
Disease control Stopped earlyThis is a Phase I/IIa, multicenter, open-label, consecutive cohorts, dose-escalation study of BT-001 with repeated IT administrations alone and in combination with IV infusions of pembrolizumab.
Phase 1/2 • Sponsor: Transgene • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eczema cream shows promise for Long-Term use in large trial
Disease control CompletedThis study was a Phase 3, multicenter, open-label extension study of the long-term safety of roflumilast cream 0.15% (completers of studies ARQ-151-311 or ARQ-151-312 aged ≥6 years and ARQ-151-315 rollovers who turned 6 years of age on study) or roflumilast cream 0.05% (ARQ-151-3…
Phase 3 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug cocktail aims to outsmart lung cancer resistance
Disease control Recruiting nowThis phase Ib trial evaluates the best dose and side effects of MRX-2843 when given in combination with osimertinib in treating patients with EGFR gene mutant non-small cell lung cancer that has spread to other places in the body (advanced). MRX-2843 and osimertinib may stop the …
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Heart procedure may stop bladder bleeding without blood thinners
Disease control Recruiting nowThe etiology of the radiation cystitis is a pelvic irradiation generally performed as part of the treatment of prostate cancer. The incidence is 50,000 new cases per year. Approximately 35% of prostate cancer treatment is radiotherapy. The prevalence of haematuric radiation cysti…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Parkinson's drug shows promise in Year-Long trial
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease.
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo for kids with resistant leukemia shows early promise but study halted
Disease control Stopped earlyThis study is about an anticancer drug called ponatinib which is a tyrosine kinase inhibitor given with chemotherapy to children, teenagers, and young adults up to 21 years of age with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia who have relapsed or are resistan…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Proton beam therapy plus chemo aims to improve Post-Surgery treatment for advanced endometrial cancer
Disease control Stopped earlyA phase 2 study with the primary objective of testing treatment compliance of Upfront Intensity Modulated Proton Beam Therapy (IMPT) and Concurrent Chemotherapy (UPPROACH) for Post-operative Treatment in Loco-regionally Advanced Endometrial Cancer is non-inferior to the historic …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC